Event
PEGS Europe 2026 | Meet Axxam in Lisbon
Tommaso Tosi
Principal Scientist | Biochemistry | Assay Development
From protein engineering to therapeutic development, transforming promising biological molecules into viable drug candidates requires reliable experimental strategies and a deeper understanding of molecular interactions.
This November, Axxam will attend PEGS Europe 2026 in Lisbon, an international conference dedicated to protein and antibody engineering, bringing together scientists and industry experts to discuss advances in biologics research and development.
Representing Axxam will be Tommaso Tosi, Principal Scientist, Biochemistry / Assay Development, who will be available to exchange scientific perspectives and discuss challenges in early drug discovery.
The right assay makes the difference
Behind every promising therapeutic candidate lies a series of critical experimental decisions.
At Axxam, our expertise in biochemistry and assay development supports the investigation of molecular interactions, target activity, and compound behavior through tailored experimental approaches.
From biochemical assay design and optimization to screening and compound characterization, we develop robust and reproducible methods to generate meaningful data and support informed decisions throughout early drug discovery.
Let's talk science in Lisbon
Are you attending PEGS Europe 2026?
Connect with Tommaso Tosi to discuss your research challenges, exchange ideas on assay development, and discover how Axxam’s scientific expertise can support your discovery programs.